Welcome to our dedicated page for NORTHROP GRUMMAN /DE/ SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NORTHROP GRUMMAN /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NORTHROP GRUMMAN /DE/'s regulatory disclosures and financial reporting.
Turley James S reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director James S. Turley received an award of 349 shares of Common Stock valued at $552.17 per share. The shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Turley holds a total of 6,738 shares, including 635 shares of common stock and 6,103 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s current and 2011 long-term incentive stock plans.
SCHOEWE THOMAS M reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman Corp. director Thomas M. Schoewe received an award of 349 shares of common stock-equivalent units on May 20, 2026. The grant was priced at $552.17 per share and was made under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Schoewe’s holdings total 16,737 share equivalents, including 3,160 shares of common stock and 13,577 stock units (with dividends) held in plan-related stock unit accounts.
Northrop Grumman director Gary Roughead received an equity award of 349 common shares, valued at $552.17 per share, as a grant under the company’s long-term incentive plan. After this award, he directly holds 12,210 common shares. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan and are treated as an acquisition exempt from short-swing profit rules. Footnotes note that additional stock units, including dividend equivalents under current and prior long-term incentive plans, are maintained in this account but were not part of this new grant.
Ross Kimberly A. reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Kimberly A. Ross received an equity award of 349 shares of common stock, valued at $552.17 per share, as compensation. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Ross directly holds 1,612 shares, including dividends credited in stock unit accounts under the 2024 plan and the earlier 2011 Long-Term Incentive Stock Plan.
KRISHNA ARVIND reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Arvind Krishna received an award of 349 shares of common stock on May 20, 2026, at a reference price of $552.17 per share. The filing explains these shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Krishna directly holds 2,666 shares of common stock, including shares and dividends accumulated in stock unit accounts under the company’s long‑term incentive plans.
Northrop Grumman director Christopher W. Grady reported a compensation-related stock award. On May 20, 2026, he acquired 349 shares of Common Stock at a stated value of $552.17 per share through a grant under the Northrop Grumman 2024 Long-Term Incentive Stock Plan.
These shares were deferred into a stock unit account in a transaction exempt under Rule 16b-3. Following the award, Grady directly holds 421 shares of Northrop Grumman common stock, including amounts and dividends maintained in the stock unit account pursuant to the company’s long-term incentive plans.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Marianne Catherine Brown received a grant of 349 shares of common stock on May 20, 2026, as a compensation award. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Brown directly holds a total of 11,415 shares of Northrop Grumman common stock, including shares and dividends held in stock unit accounts under the company’s long-term incentive plans.
Northrop Grumman director David P. Abney reported an award of common stock tied to the company’s long-term incentive plan. On May 20, 2026, he acquired 349 shares of Northrop Grumman common stock at $552.17 per share in a grant classified as a compensation-related acquisition rather than an open-market purchase.
According to the filing, these 349 shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, Abney’s directly held position is reported as 2,824 shares, consisting of 2,475 shares of common stock and 349 stock units, including dividends credited to the stock unit account.
Capital International Investors reports 7,321,667 shares (5.2%) of Northrop Grumman common stock. Amendment No. 9 to a Schedule 13G/A states CII is deemed beneficial owner of 7,321,667 shares of Common Stock (CUSIP 666807102) of Northrop Grumman Corp. as of 03/31/2026. The filing lists 7,124,472 shares subject to sole voting power and 7,321,667 shares subject to sole dispositive power, based on 141,921,621 shares believed outstanding.
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.